Brainstorm Cell Therapeutics reported $122K in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Biogen USD 2.38B 15.8M Sep/2026
Brainstorm Cell Therapeutics USD 122K 36K Mar/2026
Cipla INR 65.92B 3.73B Sep/2026
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 4.11M 1.77M Jun/2026
CSL USD 4.32B 1.35B Dec/2025
Cytokinetics USD 24.43M 17.6M Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 518.59M 65.26M Sep/2026
Mesoblast USD 57.66M 14.36M Jun/2026